Lilly France

Lilly France is the French subsidiary of Eli Lilly and Company, a global leader in the pharmaceutical industry. The company maintains a significant presence in France with its administrative headquarters in Neuilly-sur-Seine and a major industrial complex in Fegersheim. The Fegersheim site is one of the group's largest manufacturing facilities worldwide, specializing in the production and packaging of injectable medicines for diabetes and other conditions. Lilly France focuses on core therapeutic areas including metabolic disorders, oncology, immunology, and neuroscience. The company plays a vital role in the French healthcare ecosystem through clinical research, industrial investment, and the distribution of innovative therapies. Its portfolio includes blockbuster treatments such as insulin analogs, GLP-1 receptor agonists, and targeted cancer therapies.